Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 9/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 7/20 | 0.42 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.39 |
| ▸ | FLT3 | P36888 | 2/20 | 0.39 |
| ▸ | IKBKB | O14920 | 1/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.37 |
| ▸ | NEK1 | Q96PY6 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30709266 | 0.87 | CYP11B1 (0.44) | CYP11B2CYP11B1KDM4EMAPK14 | |
| SCHEMBL30709426 | 0.85 | CYP11B1 (0.40) | CYP11B2CYP11B1CYP17A1CYP19A1MAPK14 | |
| SCHEMBL30709400 | 0.85 | CYP11B2 (0.38) | CYP11B2CYP11B1CYP17A1CYP19A1FLT3 | |
| SCHEMBL30709345 | 0.85 | ABCG2 (0.36) | FLT3ABCG2KDM4E | |
| SCHEMBL30709191 | 0.85 | CYP11B1 (0.40) | CYP11B2CYP11B1CYP17A1KDM4EMAPK14 | |
| SCHEMBL30709336 | 0.84 | CYP11B1 (0.44) | CYP11B2CYP11B1CYP17A1CYP19A1KDM4E | |
| SCHEMBL30709418 | 0.84 | PTGER4 (0.37) | ABCG2KDM4EGLAGAA | |
| SCHEMBL22148523 | 0.84 | CYP1A2 (0.36) | ABCG2KDM4E | |
| SCHEMBL22148761 | 0.83 | MAPK14 (0.41) | CYP11B2CYP11B1KDM4EMAPK14 | |
| SCHEMBL22148892 | 0.83 | MAPK14 (0.41) | CYP11B2CYP11B1KDM4EMAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | KYULUX, INC. (JP) | 2023-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | NDUFV3, NDUFV2, CRY2 | CYP11B2 244/4885CYP11B1 467/4885CYP17A1 1658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.